Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc. > A second pandemic...
View:
Post by prophetoffactz on Jun 22, 2023 3:50pm

A second pandemic...

There is an acute phase of COVID and it leaves behind long-term damage to those infected that can accumulate with the number of infections. Even assymptomatic and mild cases can cause lasting damage and patients may require monitoring. Policy makers have tried to move on and ignore this; but the bill is now having to be paid. When policy markers take into account the long term costs of this virus on human  health and the health care system they may once again return to the importance of diagnostics and prevention which have been substantially abandoned.

“We know that Covid has caused direct [Covid leading to new cardiovascular disease], indirect [reduced treatment and prevention of cardiovascular disease] and long-term effects [cardiovascular disease and long Covid],” Prof John Greenwood

...When will the UK and other countries start including COVID sequelae in their risk assessments and strategies? When will the "government" address waiting times and ambulance responses? Bloody shambles.

Health bosses warn of heart disease emergency in England

Charity calls for prioritisation of NHS heart care after nearly 100,000 excess deaths since March 2020
Health bosses warn of heart disease emergency in England | Heart disease | The Guardian

Comment by wizzdumb on Jun 22, 2023 6:37pm
Clots are a big part of this, hence significant growth and opportunity for Kinlytic. 
Comment by prophetoffactz on Jun 23, 2023 3:07pm
@lisa_iannattone This is a paradigm shift in medicine. It really is. Linking a virus to the development of cardiovascular disease and metabolic disease is paradigm shifting research. It really is. This is bigger than just covid. Any official or institution that talks up research on LC prevention while they also discourage covid testing and work to make access to PCR/ RATs increasingly ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities